Picard Medical / SynCardia Highlight Total Artificial Heart on BTV Program Airing on FOX Business News

Core Viewpoint - Picard Medical, Inc. is promoting its SynCardia Total Artificial Heart (STAH) technology, which is the first total artificial heart approved by both the U.S. FDA and Health Canada, through a feature on BTV Business Television, highlighting its significance in treating patients with severe heart failure [1][5]. Group 1: Company Overview - Picard Medical, Inc. is the parent company of SynCardia Systems, LLC, which is based in Tucson, Arizona, and is the leader in total artificial heart technology for patients with end-stage heart failure [8]. - The SynCardia Total Artificial Heart (STAH) is the only commercially available artificial heart in the United States and Canada, with over 2,100 implants performed across 27 countries, making it the most widely used and extensively studied artificial heart technology globally [3][8]. Group 2: Technology and Development - The STAH replaces both left and right ventricles and all four heart valves, restoring circulation in patients with severe biventricular heart failure who are at risk of imminent death without mechanical circulatory support [3]. - The company is also developing a next-generation, fully implantable artificial heart platform aimed at improving patient mobility and quality of life by eliminating external pneumatic drivers [4]. Group 3: Market Awareness and Outreach - The upcoming segment on BTV Business Television aims to raise awareness of advanced heart failure therapies, which is increasingly important as the number of patients needing mechanical circulatory support continues to grow [5]. - BTV Business Television has been a long-running investment-focused program that profiles emerging companies and technologies, providing exposure to retail and institutional investors [7].